当前位置: X-MOL 学术Neuropharmacology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1
Neuropharmacology ( IF 4.6 ) Pub Date : 2018-10-23 , DOI: 10.1016/j.neuropharm.2018.10.033
Yu-Shu Liu , Jhih-Wen Hsu , Hsiao-Yun Lin , Sheng-Wei Lai , Bor-Ren Huang , Cheng-Fang Tsai , Dah-Yuu Lu

Glioblastoma (GBM), the most aggressive brain tumor, has a poor prognosis due to the ease of migration to surrounding healthy brain tissue. Recent studies have shown that bradykinin receptors are involved in the progression of various cancers. However, the molecular mechanism and pathological role of bradykinin receptors remains unclear. We observed the expressions of two major bradykinin receptors, B1R and B2R, in two different human GBM cell lines, U87 and GBM8901. Cytokine array analysis showed that bradykinin increases the production of interleukin (IL)-8 in GBM via B1R. Higher B1R levels correlate with IL-8 expression in U87 and GBM8901. We observed increased levels of phosphorylated STAT3 and SP-1 in the nucleus as well. Using chromatin immunoprecipitation assay, we found that STAT3 and SP-1 mediate IL-8 expression, which gets abrogated by the inhibition of FAK and STAT3. We further demonstrated that IL-8 expression and cell migration are also regulated by the SP-1. In addition, expression levels of STAT3 and SP-1 positively correlate with clinicopathological grades of gliomas. Interestingly, our results found that inhibition of HDAC increases IL-8 expression. Moreover, stimulation with bradykinin caused increases in acetylated SP-1 and p300 complex formation, which are abrogated by inhibition of FAK and STAT3. Meanwhile, knockdown of SP-1 and p300 decreased the augmentation of bradykinin-induced IL-8 expression. These results indicate that bradykinin-induced IL-8 expression is dependent on B1R which causes phosphorylated STAT3 and acetylated SP-1 to translocate to the nucleus, hence resulting in GBM migration.



中文翻译:


缓激肽 B1 受体通过 STAT3 和 SP-1 的相互作用促进白细胞介素 8 的产生和胶质母细胞瘤的迁移



胶质母细胞瘤(GBM)是最具侵袭性的脑肿瘤,由于容易迁移到周围健康脑组织,因此预后较差。最近的研究表明,缓激肽受体参与多种癌症的进展。然而,缓激肽受体的分子机制和病理作用仍不清楚。我们观察了两种主要缓激肽受体 B1R 和 B2R 在两种不同的人 GBM 细胞系 U87 和 GBM8901 中的表达。细胞因子阵列分析表明,缓激肽通过 B1R 增加 GBM 中白细胞介素 (IL)-8 的产生。 U87 和 GBM8901 中较高的 B1R 水平与 IL-8 表达相关。我们还观察到细胞核中磷酸化 STAT3 和 SP-1 的水平增加。使用染色质免疫沉淀测定,我们发现 STAT3 和 SP-1 介导 IL-8 的表达,而抑制 FAK 和 STAT3 可以消除 IL-8 的表达。我们进一步证明 IL-8 表达和细胞迁移也受到 SP-1 的调节。此外,STAT3和SP-1的表达水平与胶质瘤的临床病理分级呈正相关。有趣的是,我们的结果发现抑制 HDAC 会增加 IL-8 的表达。此外,缓激肽刺激导致乙酰化 SP-1 和 p300 复合物形成增加,而抑制 FAK 和 STAT3 可以消除这种现象。同时,敲除 SP-1 和 p300 会降低缓激肽诱导的 IL-8 表达的增强。这些结果表明缓激肽诱导的IL-8表达依赖于B1R,B1R导致磷酸化STAT3和乙酰化SP-1易位至细胞核,从而导致GBM迁移。

更新日期:2018-10-23
down
wechat
bug